The consequences of Mad2l1 inactivation for chromosome structure also appear to differ with cell type: in Mad2l1-deficient HCCs we observe fewer and smaller lesions that in T-ALL. This evidence concerns the gene MAD2L1 and acute lymphoblastic leukemia.